Ignis Therapeutics
Shanghai
About Ignis Therapeutics
Ignis Therapeutics is a life science company developing innovative therapies in the field of the central nervous system. With a strong commitment to self-discovery and a development strategy to advance the treatment paradigm, Ignis Therapeutics transforms the approach to treating CNS conditions. Ignis Therapeutics is dedicated to developing products that significantly improve the lives of patients while also providing additional therapeutic options for physicians.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $182.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: ignistherapeutics.comen
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/ignis-therapeutics-72572 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.